Methodology Pricing

Kymera Therapeutics, Inc.

KYMR

HealthcareBiotechnologyNASDAQ

$78.16

Market Cap: $6.38B

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

People

This section is coming soon.

SweetValueLab © 2026

Methodology Pricing About

Not financial advice. Data may be delayed.